These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28711714)

  • 1. Review - An update on the use of oral phospholipid excipients.
    van Hoogevest P
    Eur J Pharm Sci; 2017 Oct; 108():1-12. PubMed ID: 28711714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Phospholipid Complex-a Go Through Strategy for Enhanced Oral Bioavailability.
    Kuche K; Bhargavi N; Dora CP; Jain S
    AAPS PharmSciTech; 2019 Jan; 20(2):43. PubMed ID: 30610392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into the formation of drug-monoacyl phosphatidylcholine solid dispersions for oral delivery.
    Gautschi N; Van Hoogevest P; Kuentz M
    Eur J Pharm Sci; 2017 Oct; 108():93-100. PubMed ID: 27240778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers.
    Jebastin K; Narayanasamy D
    J Liposome Res; 2023 Mar; 33(1):1-33. PubMed ID: 35543241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
    Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zein as a Pharmaceutical Excipient in Oral Solid Dosage Forms: State of the Art and Future Perspectives.
    Berardi A; Bisharat L; AlKhatib HS; Cespi M
    AAPS PharmSciTech; 2018 Jul; 19(5):2009-2022. PubMed ID: 29736888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of natural and synthetic phospholipids as pharmaceutical excipients.
    van Hoogevest P; Wendel A
    Eur J Lipid Sci Technol; 2014 Sep; 116(9):1088-1107. PubMed ID: 25400504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring the multi-functional properties of phospholipids for simple to complex self-assemblies.
    Waghule T; Saha RN; Alexander A; Singhvi G
    J Control Release; 2022 Sep; 349():460-474. PubMed ID: 35841998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex.
    Wu Z; Guo D; Deng L; Zhang Y; Yang Q; Chen J
    Drug Dev Ind Pharm; 2011 Jan; 37(1):103-12. PubMed ID: 21073324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.
    Fong SY; Martins SM; Brandl M; Bauer-Brandl A
    J Pharm Sci; 2016 Mar; 105(3):1113-23. PubMed ID: 26886329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phospholipid as a solubility- and permeability-enhancing excipient for the improved delivery of the bioactive phytoconstituents of Bacopa monnieri.
    Saoji SD; Dave VS; Dhore PW; Bobde YS; Mack C; Gupta D; Raut NA
    Eur J Pharm Sci; 2017 Oct; 108():23-35. PubMed ID: 27590125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing excipient emulsions to increase nutraceutical bioavailability: emulsifier type influences curcumin stability and bioaccessibility by altering gastrointestinal fate.
    Zou L; Liu W; Liu C; Xiao H; McClements DJ
    Food Funct; 2015 Aug; 6(8):2475-86. PubMed ID: 26165514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity Study of a Self-nanoemulsifying Drug Delivery System Containing N-methyl pyrrolidone.
    Agrawal AG; Kumar A; Gide PS
    Drug Res (Stuttg); 2015 Aug; 65(8):446-8. PubMed ID: 25823509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Phospholipids Boost or Attenuate Drug Absorption? In Vitro and In Vivo Evaluation of Mono- and Diacyl Phospholipid-Based Solid Dispersions of Celecoxib.
    Jacobsen AC; Ejskjær L; Brandl M; Holm R; Bauer-Brandl A
    J Pharm Sci; 2021 Jan; 110(1):198-207. PubMed ID: 32827494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the in vitro cytotoxicity among phospholipid-based parenteral drug delivery systems: Emulsions, liposomes and aqueous lecithin dispersions (WLDs).
    Płaczek M; Wątróbska-Świetlikowska D; Stefanowicz-Hajduk J; Drechsler M; Ochocka JR; Sznitowska M
    Eur J Pharm Sci; 2019 Jan; 127():92-101. PubMed ID: 30342174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid excipients - matrix agents for sustained drug delivery.
    Rosiaux Y; Jannin V; Hughes S; Marchaud D
    J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.